Skip to content

Germany's Ashwagandha Supplements Face Safety Scrutiny Amid Lax Regulations

A popular herb with bold health claims—but little proof. Experts reveal why Germany's ashwagandha market could be putting consumers at risk.

The image shows an advertisement for Ayer's Catholic Pills, a safe, pleasant and reliable family...
The image shows an advertisement for Ayer's Catholic Pills, a safe, pleasant and reliable family medicine. It features a poster with text and images of children, suggesting that the medicine is safe and reliable.

Germany's Ashwagandha Supplements Face Safety Scrutiny Amid Lax Regulations

Ashwagandha supplements remain widely available in Germany despite growing concerns over their safety. Authorities have warned that these products lack proper regulation and may pose serious health risks. Pregnant women, breastfeeding mothers, and children are being urged to avoid them entirely. In Germany, dietary supplements like ashwagandha only need registration with the Federal Office of Consumer Protection and Food Safety. The agency does not test these products for safety or effectiveness before they hit the market. Unlike some countries, Germany has no legally binding maximum dosage limits for ashwagandha, leaving consumers exposed to potential risks.

A 2026 market study in North Rhine-Westphalia found that many ashwagandha products sold in Germany exceed dosage thresholds set by Poland. Higher doses have been linked to side effects such as nausea, dizziness, headaches, and even liver damage. Dutch authorities have already recorded 12 cases of liver injury connected to a supplement containing the herb. The Federal Institute for Risk Assessment (BfR) and other European bodies advise against taking ashwagandha due to insufficient safety data. While small studies suggest it may reduce stress and improve sleep when taken for six to eight weeks, these findings are not conclusive. Claims that ashwagandha promotes balance, lowers cortisol, or boosts metabolism lack strong scientific backing. The herb’s active compounds, withanolides, have shown anti-tumour effects in lab experiments. However, no human clinical trials have confirmed these results. Without stricter oversight, experts warn that consumers could face unnecessary health dangers.

Ashwagandha supplements continue to be sold in Germany with minimal regulation. The lack of dosage limits and proven safety data raises concerns, particularly for vulnerable groups. Authorities stress the need for caution until further research clarifies the risks and benefits.

Read also:

Latest